RENAISSANCE TECHNOLOGIES LLC - 31 Dec 2025 SCHEDULE 13G/A Report for CORCEPT THERAPEUTICS INCORPORATED Common Stock, $0.001 par value (CORT)

Filing Manager
RENAISSANCE TECHNOLOGIES LLC
Reporting Manager
Renaissance Technologies LLC
Security
CORCEPT THERAPEUTICS INCORPORATED Common Stock, $0.001 par value
Symbol
CORT
Shares outstanding
105,274,735 shares
Disclosed Ownership
5,758,528 shares
Ownership
5.5%
Form type
SCHEDULE 13G/A
Filing time
12 Feb 2026, 14:12:24 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Renaissance Technologies LLC 5.5% 5,758,528 5,758,528 0 Brian Felczak Chief Financial Officer
Renaissance Technologies Holdings Corporation 5.5% 5,758,528 5,758,528 0 Brian Felczak Vice President